Deutsche Bank’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-200
Closed -$1K 5890
2014
Q1
$1K Hold
200
﹤0.01% 5426
2013
Q4
$2K Buy
+200
New +$37.2K ﹤0.01% 5167

Other funds holding CLB

Deutsche Bank's CLB Position: Q1 2026 in Review

Deutsche Bank increased its Core Laboratories (CLB) stake by 4.7% in Q1 2026, buying an estimated $32.5K and bringing the position to 40,615 shares worth $682K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Deutsche Bank first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $87.8M in Q1 2016. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Deutsche Bank held 40,615 shares of Core Laboratories worth $682K as of Q1 2026.
  • Deutsche Bank bought 1,818 Core Laboratories shares in Q1 2026, an estimated $32.5K.
  • Core Laboratories made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2413 holding.
  • Deutsche Bank first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Core Laboratories position peaked at $87.8M in Q1 2016.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.